RC June 13, 2018 AGM Panel – Meeting the Advocacy Challenge for the Health Innovation Ecosystem

Cynthia Stewart Director, R&D Alliances, GE Healthcare Canada What, in your view, is the greatest imperative for your sector right now and what does your sector require to be a fully engaged partner in Canada’s health innovation system? While it has the potential to radically change the healthcare system for the better, the adoption of new technologies and medicines is a challenging, multistep pro. [...] The pharmaceutical industry in particular is not currently seen as a valued partner to government and as a result, its industry association is faced with the challenging task of assisting with the cost containment efforts that are a priority Meeting the Advocacy Challenge for the Health Innovation Ecosystem – June 13, 2018 1 for government while at the same time continuing to advocate for more inv. [...] Are you of the view that the government (and other sectors for that matter) understand and support your sector’s strategic and necessary role in building a robust health innovation system in Canada? If yes, how are they doing so? If not, what are you doing to foster that understanding? How can other sectors help in this regard? While government appreciates the role of industry in creating and main. [...] While industry exists in a competitive environment, greater transparency of available data is necessary to educate both government and the public about the important role of industry in the broader health research and innovation ecosystem. [...] Collaborative efforts, however, are hindered by the siloed nature of the health research and innovation ecosystem, as evidenced by the unsuccessful proposal for a healthcare Meeting the Advocacy Challenge for the Health Innovation Ecosystem – June 13, 2018 2 Innovation Supercluster.